COVID-19 a global crisis: Features, complications and suggested treatments

Author:

M. Abo-Elela Mustafa,A. ElKasabgy Nermeen

Abstract

<p><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-ascii-theme-font: minor-bidi; mso-fareast-font-family: PMingLiU; mso-hansi-theme-font: minor-bidi; mso-bidi-font-family: PMingLiU; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: EN-US;">Coronavirus disease&nbsp;2019 (COVID-19); caused by the novel coronavirus (SARS-CoV-2)&nbsp;is the talk of everyone all over the world in 2020 since it has been considered as a public health emergency of international concern by WHO in 30<sup>th</sup> January, 2020. COVID-19 is a highly transmittable disease with different symptoms which can vary from mild to severe and life threatening. Scientists all over the world are working on finding a treatment or vaccine for this disease. All of these studies are currently not finished yet during writing this review. However, in this review a summary about the current status of these studies is given. This summary includes medicinal plants and natural products, antivirals like </span><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-ascii-theme-font: minor-bidi; mso-fareast-font-family: 'Times New Roman'; mso-hansi-theme-font: minor-bidi; mso-bidi-font-family: PMingLiU; color: #2e2e2e; mso-font-kerning: .5pt; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: EN-US;">remdesivir, favipiravir,</span><strong><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-ascii-theme-font: minor-bidi; mso-fareast-font-family: PMingLiU; mso-hansi-theme-font: minor-bidi; mso-bidi-font-family: PMingLiU; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: EN-US;"> </span></strong><span style="font-size: 10.0pt; font-family: 'Arial',sans-serif; mso-ascii-theme-font: minor-bidi; mso-fareast-font-family: 'Times New Roman'; mso-hansi-theme-font: minor-bidi; mso-bidi-font-family: PMingLiU; color: #2e2e2e; mso-font-kerning: .5pt; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: EN-US;">oseltamivir and nelfinavir as well as other miscellaneous drugs like chloroquine, hydroxychloroquine and ivermectin which showed promising results in treating COVID-19. In conclusion, the review recommends conducting further investigations worldwide and reporting them in peer-reviewed publications to aid in improving the drugs&rsquo; dosing regimens and clinical studies. </span></p>

Publisher

Pharaoh Academy International Publishing Co., Limited

Reference123 articles.

1. WHO. SARS (Severe Acute Respiratory Syndrome). [cited 2020 18th May]; Available from: https://www.who.int/ith/diseases/sars/en/

2. WHO. Middle East respiratory syndrome coronavirus (MERS-CoV). [cited 2020 18th May]; Available from: https://www.who.int/emergencies/mers-cov/en/

3. Sifuentes-Rodríguez E, Palacios-Reyes D. COVID-19: The outbreak caused by a new coronavirus. Boletin Medico del Hospital Infantil de Mexico. 2020; 77(2): 47-53.

4. Paraskevis D, Kostaki EG, Magiorkinis G, Panayiotakopoulos G, Sourvinos G, Tsiodras S. Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event. Infection, Genetics and Evolution. 2020; 79: 104212.

5. WHO. WHO Timeline - COVID-19. [cited 2020 18th May]; Available from: https://www.who.int/news-room/detail/27-04-2020-who-timeline---covid-19

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3